Signaling of MiRNAs-FOXM1 in Cancer and Potential Targeted Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|14|10|1192-1202

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.10, 2013-09, pp. : 1192-1202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting CSC-Related miRNAs for Cancer Therapy by Natural Agents

By  

Current Drug Targets, Vol. 13, Iss. 14, 2012-12 ,pp. : 1858-1868

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: MiRNAs as Legitimate Targets for Cancer Therapy)

By  

Current Drug Targets, Vol. 14, Iss. 10, 2013-01 ,pp. : 1093-1093

Bentham Science Publishers

Access to resources Recommend Favorite

OncomicroRNAs-Mediated Tumorigenesis: Implication in Cancer Diagnosis and Targeted Therapy

By  

Current Cancer Drug Targets, Vol. 17, Iss. 1, 2016-12 ,pp. : 40-47

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs (miRNAs) in Colorectal Cancer: From Aberrant Expression Towards Therapy

By  

Current Pharmaceutical Design, Vol. 19, Iss. 7, 2013-02 ,pp. : 1242-1252

Bentham Science Publishers

Access to resources Recommend Favorite

Vitamin D and miRNAs in Cancer

By  

Current Gene Therapy, Vol. 14, Iss. 4, 2014-01 ,pp. : 269-275

Bentham Science Publishers

Access to resources Recommend Favorite